Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Historical Holders from Q1 2023 to Q1 2025

Symbol
ELVN on Nasdaq
CUSIP
29337E102
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
48.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
49.6M
Holdings value
$1.12B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
110
Number of buys
58
Number of sells
-36
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fairmount Funds Management LLC 6.6% $63M 3.2M Fairmount Funds Management LLC Dec 31, 2024
Polar Capital Holdings Plc 4.89% $47M 2.39M Polar Capital Holdings Plc Dec 31, 2024

Institutional Holders of Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 72K $1.42M -$52.5K $19.68 10
2024 Q4 49.6M $1.12B +$24.8M $22.50 110
2024 Q3 47.7M $1.22B -$20.8M $25.54 100
2024 Q2 48.3M $1.13B +$91.7M $23.37 92
2024 Q1 44.5M $781M +$95.5M $17.59 72
2023 Q4 39M $540M -$1.28M $13.84 61
2023 Q3 39.1M $534M -$2.18M $13.66 61
2023 Q2 39.1M $798M +$113M $20.41 61
2023 Q1 33.6M $735M +$735M $21.90 44